Supha Pharmachem Limited
BSE: SUPHA · Trading & Distributors
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Supha Pharmachem Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Remedium Lifecare Limited is an Indian enterprise specialising in the trading and distribution of advanced pharmaceutical intermediates, active pharmaceutical ingredients, and specialty chemicals. The company acts as a strategic intermediary in the pharmaceutical supply chain, connecting manufacturers with generic drug producers.
Business Model
The company operates as a merchant exporter and domestic supplier, leveraging a lean infrastructure to manage high-volume trade of complex chemical synthesis products. It generates revenue by sourcing chemical products from domestic and international manufacturers for supply to the pharmaceutical industry.
Management Commentary
Management has focused on rebranding the entity to align with the life sciences sector and has implemented corporate actions such as stock splits and bonus issues to enhance market liquidity.
Growth Outlook
Growth is driven by the company's strategic shift toward high-value chemical distribution and its role in the expanding Indian pharmaceutical supply chain. The firm continues to focus on increasing its market presence through active trading of specialised chemical reagents.
Key Risks
- Supply Chain Volatility. As a trading entity, the company is highly susceptible to disruptions in the global pharmaceutical supply chain and fluctuations in raw material availability.
- Regulatory Compliance. The business must adhere to stringent domestic and international regulations governing the trade and handling of pharmaceutical intermediates and specialty chemicals.
- Market Competition. The Indian chemical trading landscape is highly competitive, which may exert pressure on profit margins and market share.
- Currency Fluctuation. Exposure to international markets introduces risks related to foreign exchange volatility, which can impact the cost of imports and export revenues.
Start your research today
Unlock AI insights, financials, peers and live data on Supha Pharmachem Limited and 5,000+ companies — free.
Peers · Trading & Distributors
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Supha Pharmachem LimitedSUPHA | ₹26 Cr | — | — | — | 0.0% | — | — | — |
Veritas (India)VERITAS | ₹445 Cr | 8.63 | 7.06 | -24.1% | 3.9% | 1.9% | 2.7% | -55.4% |
Kothari ProductsKOTHARIPRO | ₹407 Cr | 179.58 | -12.12 | -18.3% | -5.1% | -0.2% | -2.3% | -9.8% |
Rotographics (India) LimitedRGIL | ₹404 Cr | 94.62 | 326.54 | 4987.7% | 3.0% | 12.6% | 17.2% | — |
Polo Queen Industrial and Fintech LimitedPQIF | ₹333 Cr | 141.71 | 64.71 | -5.7% | 7.0% | 1.3% | 2.5% | -79.1% |
Constronics Infra Ltd.CONSTRONIC | ₹61 Cr | — | — | — | 5.5% | — | — | -24.7% |
As of Mar 2025
Financials
Supha Pharmachem Limited
BSE: SUPHA · Trading & Distributors
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Supha Pharmachem Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Remedium Lifecare Limited is an Indian enterprise specialising in the trading and distribution of advanced pharmaceutical intermediates, active pharmaceutical ingredients, and specialty chemicals. The company acts as a strategic intermediary in the pharmaceutical supply chain, connecting manufacturers with generic drug producers.
Business Model
The company operates as a merchant exporter and domestic supplier, leveraging a lean infrastructure to manage high-volume trade of complex chemical synthesis products. It generates revenue by sourcing chemical products from domestic and international manufacturers for supply to the pharmaceutical industry.
Management Commentary
Management has focused on rebranding the entity to align with the life sciences sector and has implemented corporate actions such as stock splits and bonus issues to enhance market liquidity.
Growth Outlook
Growth is driven by the company's strategic shift toward high-value chemical distribution and its role in the expanding Indian pharmaceutical supply chain. The firm continues to focus on increasing its market presence through active trading of specialised chemical reagents.
Key Risks
- Supply Chain Volatility. As a trading entity, the company is highly susceptible to disruptions in the global pharmaceutical supply chain and fluctuations in raw material availability.
- Regulatory Compliance. The business must adhere to stringent domestic and international regulations governing the trade and handling of pharmaceutical intermediates and specialty chemicals.
- Market Competition. The Indian chemical trading landscape is highly competitive, which may exert pressure on profit margins and market share.
- Currency Fluctuation. Exposure to international markets introduces risks related to foreign exchange volatility, which can impact the cost of imports and export revenues.
Start your research today
Unlock AI insights, financials, peers and live data on Supha Pharmachem Limited and 5,000+ companies — free.
Peers · Trading & Distributors
As of Mar 2025